Motor cortex stimulation for chronic neuropathic pain: results of a double-blind randomized study
Open Access
- 9 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 144 (10), 2994-3004
- https://doi.org/10.1093/brain/awab189
Abstract
Motor cortex stimulation via surgically implanted electrodes has been used as an off-label treatment for chronic neuropathic pain, but its efficacy has not been fully established. We aimed to objectively study the efficacy of motor cortex stimulation and characterize potential predictors of response. In this randomized, double-blind, sham-controlled, single centre trial, we recruited 18 patients with chronic neuropathic pain who did not adequately respond to conventional treatment and had a numerical pain rating scale (NRS) score ≥6. Patients were initially assigned to receive 3 months of active (‘on’) or sham (‘off’) stimulation in a double-blind cross-over phase. This was followed by a 3-month single-blind phase, and 6 months of open-label follow-up. A meaningful response in our trial was defined as a ≥30% or 2-point reduction in NRS scores during active stimulation. Using Bayesian statistics, we found a 41.4% probability of response towards on versus off motor cortex stimulation. The probability of improvement during active stimulation (double-blind, single-blind and open-label phases) compared to baseline was 47.2–68.5%. Thirty nine per cent of the patients were considered long-term responders, 71.4% of whom had facial pain, phantom limb pain or complex regional pain syndrome. In contrast, 72.7% of non-responders had either post-stroke pain or pain associated with brachial plexus avulsion. Thirty-nine per cent of patients had a substantial postoperative analgesic effect after electrode insertion in the absence of stimulation. Individuals with diagnoses associated with a good postoperative outcome or those who developed an insertional effect had a near 100% probability of response to motor cortex stimulation. In summary, we found that ∼40% of patients responded to motor cortex stimulation, particularly those who developed an insertional effect or had specific clinical conditions that seemed to predict an appropriate postoperative response.Keywords
Funding Information
- Abbott
- St Jude Medical
This publication has 41 references indexed in Scilit:
- Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugsMolecular Psychiatry, 2013
- Hippocampal Neurogenesis and the Brain Repair Response to Brief Stereotaxic Insertion of a MicroneedleStem Cells International, 2013
- Why We (Usually) Don't Have to Worry About Multiple ComparisonsJournal of Research on Educational Effectiveness, 2012
- The Placebo Effect: Advances from Different Methodological ApproachesJournal of Neuroscience, 2011
- Treatment of Poststroke Pain by Epidural Motor Cortex Stimulation With a New Octopolar LeadOperative Neurosurgery, 2011
- The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid RemifentanilScience Translational Medicine, 2011
- Intracranial electrode implantation produces regional neuroinflammation and memory deficits in ratsExperimental Neurology, 2010
- Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-AnalysisPLOS ONE, 2009
- Electrical Stimulation of the Anterior Nucleus of the Thalamus for Intractable Epilepsy: A Long‐term Follow‐up StudyEpilepsia, 2007
- Deep brain stimulation for chronic neuropathic pain: Long-term outcome and the incidence of insertional effectPain, 2006